Trial Profile
A multicenter, open-label trial to assess cognitive and psychomotor performance as surrogate parameters for driving ability under stable long term treatment with tapentadol hydrochloride prolonged-release tablets in subjects with chronic low back pain or osteoarthritis of the knee.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Oct 2015
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary)
- Indications Back pain; Musculoskeletal pain
- Focus Adverse reactions
- 21 Jun 2011 New trial record